Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,640 | 291,064 | 122,172 | 0 | 0 |
| Marketable Securities | 179,262 | N/A | N/A | 0 | 0 |
| TOTAL | $272,712 | $298,700 | $123,525 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 7,197 | 6,261 | 5,901 | N/A | N/A |
| Other Non-Current Assets | 36,793 | 872 | 2,969 | 0 | 0 |
| TOTAL | $43,990 | $7,133 | $8,870 | $N/A | $N/A |
| Total Assets | $316,702 | $305,833 | $132,395 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,931 | 706 | 2,278 | 0 | 0 |
| Accrued Expenses | 4,524 | 6,013 | 4,880 | 0 | 0 |
| TOTAL | $15,426 | $6,719 | $7,158 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 23,885 | 396 | 339 | 0 | 0 |
| TOTAL | $23,885 | $396 | $339 | $N/A | $N/A |
| Total Liabilities | $39,311 | $7,115 | $7,497 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,366 | 31,251 | 31,213 | N/A | N/A |
| Common Shares | 3 | 3 | N/A | 0 | 0 |
| Retained earnings | -115,340 | -93,669 | -75,222 | 0 | 0 |
| Other shareholders' equity | -1,535 | 0 | 197,489 | 0 | 0 |
| TOTAL | $277,391 | $298,718 | $124,898 | $0 | $0 |
| Total Liabilities And Equity | $316,702 | $305,833 | $132,395 | $0 | $0 |